Christopher E. Barbieri, MD, PhD | Authors

Articles

The Role of PARP Inhibitors in Prostate Cancer

August 09, 2016

Christopher E. Barbieri, MD, PhD, surgeon, researcher in prostate cancer, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and New-York Presbyterian, discusses the role of PARP inhibitors in castration-resistant prostate cancer.